共 50 条
- [1] Safety of rasagiline in elderly patients with Parkinson disease[J]. NEUROLOGY, 2006, 66 (09) : 1427 - 1429Goetz, CGSchwid, SREberly, SWOakes, DShoulson, I
- [2] Safety of antidepressant therapy in Parkinson's disease (PD) patients treated with rasagiline[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 63 - 64Panisset, M.Ondo, W.Schwid, S.Fitzer-Attas, C. J.Chen, J. J.
- [3] Efficacy, safety and tolerability of rasagiline as adjunctive therapy in elderly patients with Parkinson's disease[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (02) : 258 - 264Tolosa, E.Stern, M. B.
- [4] Safety of rasagiline for the treatment of Parkinson's disease[J]. EXPERT OPINION ON DRUG SAFETY, 2011, 10 (04) : 633 - 643Perez-Lloret, SantiagoRascol, Olivier
- [5] Efficacy of rasagiline monotherapy for Parkinson's disease (PD)[J]. ANNALS OF NEUROLOGY, 2005, 58 : S55 - S55Prisco, ULFitzer-Attas, COren, S
- [6] Safety and tolerability of tyramine challenge in levodopa-treated Parkinson's disease (PD) patients receiving rasagiline[J]. NEUROLOGY, 2008, 70 (11) : A58 - A59Wilkinson, JayneReichwein, SuzanneStern, Matthew
- [8] Safety, tolerabilty and satisfaction of safinamide in elderly Parkinson's disease (PD) patients.[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 651 - 651Labandeira, C. M.Alonso Losada, M. G.Koukoulis, A.
- [9] Rasagiline and apathy in patients with Parkinson's disease[J]. MOVEMENT DISORDERS, 2013, 28 : S129 - S129Martinez-Ramirez, D.Rodriguez-Violante, M.Cervantes-Arriaga, A.Morales-Briceno, H.Camacho-Ordonez, A.Gonzalez-Latapi, P.
- [10] Safety of concomitant therapy with rasagiline and antidepressants in Parkinson's disease[J]. MOVEMENT DISORDERS, 2007, 22 : S105 - S105Panisset, M.Schwid, S.Ondo, W.Fitzer-Attas, C.Chen, J. J.